Michael Shawn Moran

Insider Reports History

Entity
Individual
Location
C/O Eagle Pharmaceuticals, Inc., 50 Tice Blvd., Suite 315, Woodcliff, NJ
Signature
/s/ Brian Cahill, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Shawn Moran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EAGLE PHARMACEUTICALS, INC. EVP, Chief Commercial Officer Common Stock 32.1K $165K $5.13 Feb 28, 2022 Direct

Insider Reports Filed by Michael Shawn Moran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2022 1 $0 4 Mar 2, 2022 EVP, Chief Commercial Officer
EGRX EAGLE PHARMACEUTICALS, INC. Feb 2, 2022 1 -$33.4K 4 Feb 4, 2022 EVP, Chief Commercial Officer
EGRX EAGLE PHARMACEUTICALS, INC. Jan 31, 2022 1 -$9.65K 4 Feb 1, 2022 EVP, Chief Commercial Officer
EGRX EAGLE PHARMACEUTICALS, INC. Jan 7, 2022 1 -$4.56K 4 Jan 11, 2022 EVP, Chief Commercial Officer
EGRX EAGLE PHARMACEUTICALS, INC. Jan 5, 2022 1 -$76.6K 4 Jan 7, 2022 EVP, Chief Commercial Officer
EGRX EAGLE PHARMACEUTICALS, INC. Sep 27, 2021 0 $0 3 Oct 7, 2021 EVP, Chief Commercial Officer